Skip to content

Bicarbonate in Patients With Out-of-hospital Cardiac Arrest

Pilot Study of Bicarbonate Injection for Improving Outcome in Patients With Out-of-hospital Cardiac Arrest, Double-blind Randomized Control Trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02303548
Enrollment
50
Registered
2014-12-01
Start date
2014-10-31
Completion date
2016-02-29
Last updated
2022-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest, Metabolic Acidosis

Keywords

Sodium Bicarbonate

Brief summary

A pilot study to evaluate the effect of sodium bicarbonate administration on cardiopulmonary resuscitation results and outcomes in cardiac arrest patient with severe metabolic acidosis.

Interventions

DRUGSodium bicarbonate

Administer Sodium bicarbonate 50 mEq IV over 2 minutes

DRUGNormal saline

Placebo

Sponsors

Asan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adult cardiac arrest patient with arterial pH \<7.1 or bicarbonate \<10mmEq/L checked at 10 minutes of cardiopulmonary resuscitation

Exclusion criteria

* age \<18 trauma patient Do Not Resuscitate state

Design outcomes

Primary

MeasureTime frameDescription
Return of Spontaneous Circulation (ROSC)checked during CPR, duration of ROSC >20 minPercentage of Participants with Return of Spontaneous Circulation (ROSC)

Participant flow

Participants by arm

ArmCount
1 (Sodium Bicarbonate)
Sodium bicarbonate 50cc (50mEq) intravenous injection over 2 min Sodium bicarbonate: Administer Sodium bicarbonate 50 mEq IV over 2 minutes
25
2 (Normal Saline)
Normal saline 50cc intravenous injection over 2 min Normal saline: Placebo
25
Total50

Baseline characteristics

Characteristic1 (Sodium Bicarbonate)2 (Normal Saline)Total
Age, Continuous65.5 years
STANDARD_DEVIATION 16.4
64.1 years
STANDARD_DEVIATION 15.4
64.8 years
STANDARD_DEVIATION 16
pH6.99 units on a scale6.90 units on a scale6.95 units on a scale
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
South Korea
25 Participants25 Participants50 Participants
Sex: Female, Male
Female
7 Participants4 Participants11 Participants
Sex: Female, Male
Male
18 Participants21 Participants39 Participants
Shockable pre-hospital rhythm7 participants3 participants10 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
24 / 2521 / 25
other
Total, other adverse events
25 / 2525 / 25
serious
Total, serious adverse events
25 / 2524 / 25

Outcome results

Primary

Return of Spontaneous Circulation (ROSC)

Percentage of Participants with Return of Spontaneous Circulation (ROSC)

Time frame: checked during CPR, duration of ROSC >20 min

ArmMeasureValue (NUMBER)
1 (Sodium Bicarbonate)Return of Spontaneous Circulation (ROSC)4 ROSC percents of each group
2 (Normal Saline)Return of Spontaneous Circulation (ROSC)16 ROSC percents of each group

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026